Clinical Trial Update: Gemini Symbicort pMDI [Phase 3]

View source ↗

Summary

Clinical trial update reports completion of a Phase 3 study of Gemini Symbicort pMDI for mild or moderate asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Mild or Moderate Asthma | Phase 3 | Status: COMPLETED